Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Q32 Bio
Biotech
J&J's medtech chief out the door—Chutes & Ladders
J&J’s medtech head departs after almost 30 years. Ex-Gyroscope CEO leads new biotech. BrainStorm ditches CMO after withdrawing FDA application.
Max Bayer
,
Gabrielle Masson
Oct 27, 2023 9:30am
Maxwell Biosciences taps 3 leaders—Chutes & Ladders
Sep 23, 2022 9:30am
Lilly's longtime manufacturing chief to retire—Chutes & Ladders
Mar 12, 2021 10:13am
Ex-Intercept CMO Campagna lands at Q32
Mar 9, 2021 8:45am
Q32 Bio banks $60M as it ramps up 'immune rebalancing' programs
Oct 29, 2020 9:45am
Q32 debuts with $46M to 'rebalance' innate and adaptive immunity
May 27, 2020 7:00am
